Tci Wealth Advisors, Inc. Atara Biotherapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$4.69 - $9.84 $3,967 - $8,324	846 New	846 $7,000
Q1 2022 Apr 29, 2022	SELL	$8.44 - $16.89 $3,029 - $6,063	-359 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$14.7 - $19.89 $3,072 - $4,157	209 Added 139.33%	359 $6,000
Q3 2021 Oct 29, 2021	BUY	$11.99 - $17.9 $119 - $179	10 Added 7.14%	150 $3,000
Q2 2021 Aug 02, 2021	BUY	$12.89 - $16.58 $348 - $447	27 Added 23.89%	140 $2,000
Q1 2021 Apr 29, 2021	BUY	$14.0 - $20.72 $1,582 - $2,341	113 New	113 $2,000
Q4 2020 Jan 21, 2021	SELL	$12.67 - $26.23 $1,267 - $2,623	-100 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$12.03 - $19.94 $1,203 - $1,994	100 New	100 $1,000
Q4 2018 Jan 17, 2019	SELL	$30.9 - $42.97 $61 - $85	-2 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$35.05 - $43.5 $140 - $174	-4 Reduced 66.67%	2 $0
Q2 2018 Jul 27, 2018	BUY	$35.15 - $51.45 $210 - $308	6 New	6 $0

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.